This narrative review discusses how bronchial asthma is commonly associated with systemic comorbidities (e.g., cardiovascular, metabolic, neurodegenerative diseases) due to shared immunological pathways. It argues that recognizing these connections is essential for personalized clinical management beyond targeted asthma therapies.